Read the latest from Baszucki Group and its partners.
January 13, 2022 — The Baszucki Brain Research Fund and the Milken Institute’s Center for Strategic Philanthropy are pleased to announce that 45 scientists worldwide will receive funding to advance research for bipolar disorder therapeutic research.
December 8, 2021 — UC San Francisco has launched the Baszucki Lymphoma Therapeutics Initiative to increase the effectiveness and availability of chimeric antigen receptor T-cell (CAR T) therapy for lymphoma patients.
April 30, 2021 — Tech couple David Baszucki and Jan Ellison Baszucki have big plans to fund research and therapies for bipolar disorder. Working in partnership with the Milken Institute, the Baszuckis aim to blend philanthropy and private investments.
April 12, 2021 — The Milken Institute’s Center for Strategic Philanthropy and the Baszucki Brain Research Fund announced the launch of a dedicated grant program aimed at advancing therapeutic discovery for bipolar disorder (BD).